complete remission (pCR) and event-free survival (EFS) assessed by the Independent Blind Evaluation Committee (BIPR); key secondary research endpoints include BIPR-assessed overall survival (OS) and primary pathological response (MPR) ), etc.
Glofitamab is expected to break through the curative effect bottleneck of R/R B-NHL
Time of Update: 2021-04-18
>Glofitamab is a new type of bispecific antibody with a novel 2:1 structure. It binds bivalently to CD20 of B cells and monovalently binds to CD3 of T cells to induce T cell activation and immune response against tumor cells, thereby achieving
Umbralisib is expected to become a safe and effective treatment for R/R iNHL patients
Time of Update: 2021-04-18
Fowler and others conducted a phase IIb clinical study to evaluate the PI3Kδ/CK-1ε dual inhibitor Umbralisib in patients with relapsed or refractory indolent non-Hodgkin’s lymphoma (R/R iNHL) Efficacy and safety.
are announced, which is expected to revolutionize the treatment landscape
Time of Update: 2021-04-18
> The Chinese subgroup data of the CheckMate-649 study strengthens our confidence in promoting the continuous development of gastric cancer and gastroesophageal junction cancer immunotherapy, and is expected to comprehensively
clinical endpoint, which is expected to delay cancer recurrence
Time of Update: 2021-04-18
▎The content team editor of WuXi AppTec recently, Bristol-Myers Squibb (BMS) announced that its blockbuster PD-1 inhibitor Odivo (Navulimab) is combined with chemotherapy to treat patients with early-stage non-small cell lung cancer Positive results at the time.
Professor Han Baohui: Atelizumab is expected to become a new choice for the first-line treatment of advanced non-small cell lung cancer
Time of Update: 2021-04-18
S. Food and Drug Administration (FDA) with the success of the IMpower110 study Atilizumab is the first-line treatment for patients with metastatic NSCLC with high PD-L1 expression (TC≥50% or IC≥10%) [1].
FAO expects global cereal production to increase for the third consecutive year in 2021
Time of Update: 2021-04-17
html" class="zdbq" title="Cereal-related food information" target="_blank">Cereal FAO predicts that global cereal production will increase for the third consecutive year in 2021.
Brazil's soybean production in 2021-2022 is expected to hit a new high
Time of Update: 2021-04-17
html" class="zdbq" title="Brazil-related food information" target="_blank">Brazil will plant 40 million hectares of foodmate.
Brazil's 2020-2021 main crop production is expected to exceed 270 million tons
Time of Update: 2021-04-17
html" class="zdbq" title="Investigate relevant food information" target="_blank">survey report of the current production year released by the Brazilian Agricultural Supply Company (Conab) on April 8 shows that in 2020-2021, the planting area of Brazil’s main foodmate.
The output value of Argentina's main crops is expected to increase by 29% year-on-year in 2021
Time of Update: 2021-04-16
html" class="zdbq" title="Cereal-related food information" target="_blank">Grain Exchange in Argentina, under the favorable background of the continuous increase in global foodmate.
Russia's grain exports in 2020/21 are expected to reach 46.5 million tons
Time of Update: 2021-04-16
html" class="zdbq" title="Export-related food information" target="_blank">export In 2020, Russia’s cereal production hit a record for the second time, but the government has imposed export tariffs and quotas.
Another potential drug for COVID-19 is expected to be on the market, GSK/Vir submitted an emergency
Time of Update: 2021-04-14
Recently, GlaxoSmithKline (GSK) and Vir
BMJ Sub-Journal: The data of more than 1.9 million people in 168 countries confirm that the benefits of exercise far exceed expectations!
Time of Update: 2021-04-13
9 million people in 168 countries, and assessed premature deaths and all-cause mortality caused by lack of exercise, cardiovascular disease mortality, and non-communicable diseases (including coronaryThe incidence ofheart disease, stroke, hypertension, type 2 diabetes , dementia, depression, and various cancers).